84 related articles for article (PubMed ID: 29945324)
1. CCL22 and CCR4 Gene Polymorphisms in Myocardial Infarction: Risk Assessment of rs4359426 and rs2228428 in Iranian Population.
Noori F; Naeimi S; Zibaeenezhad MJ; Gharemirshamlu FR
Clin Lab; 2018 Jun; 64(6):907-913. PubMed ID: 29945324
[TBL] [Abstract][Full Text] [Related]
2. CCR4 C1014T and CCL22 C16A genetic variations in the Iranian patients with colorectal adenocarcinoma.
Erfani N; Ahrari S; Ahrari I; Hosseini SV
Iran J Allergy Asthma Immunol; 2014 Dec; 13(6):440-6. PubMed ID: 25148803
[TBL] [Abstract][Full Text] [Related]
3. CCL22 16C/a genetic variation is not associated with breast carcinoma in Southern Iranian population.
Erfani N; Moghaddasi-Sani F; Razmkhah M; Haghshenas MR; Talei A; Ghaderi A
Iran J Immunol; 2012 Dec; 9(4):226-33. PubMed ID: 23268288
[TBL] [Abstract][Full Text] [Related]
4. Higher circulating levels of chemokines CXCL10, CCL20 and CCL22 in patients with ischemic heart disease.
Safa A; Rashidinejad HR; Khalili M; Dabiri S; Nemati M; Mohammadi MM; Jafarzadeh A
Cytokine; 2016 Jul; 83():147-157. PubMed ID: 27152707
[TBL] [Abstract][Full Text] [Related]
5. Higher circulating levels of chemokine CCL22 in patients with breast cancer: evaluation of the influences of tumor stage and chemokine gene polymorphism.
Jafarzadeh A; Fooladseresht H; Minaee K; Bazrafshani MR; Khosravimashizi A; Nemati M; Mohammadizadeh M; Mohammadi MM; Ghaderi A
Tumour Biol; 2015 Feb; 36(2):1163-71. PubMed ID: 25722218
[TBL] [Abstract][Full Text] [Related]
6. Variants of C-C motif chemokine 22 (CCL22) are associated with susceptibility to atopic dermatitis: case-control studies.
Hirota T; Saeki H; Tomita K; Tanaka S; Ebe K; Sakashita M; Yamada T; Fujieda S; Miyatake A; Doi S; Enomoto T; Hizawa N; Sakamoto T; Masuko H; Sasaki T; Ebihara T; Amagai M; Esaki H; Takeuchi S; Furue M; Noguchi E; Kamatani N; Nakamura Y; Kubo M; Tamari M
PLoS One; 2011; 6(11):e26987. PubMed ID: 22125604
[TBL] [Abstract][Full Text] [Related]
7. Expression of MDC/CCL22 and its receptor CCR4 in rheumatoid arthritis, psoriatic arthritis and osteoarthritis.
Flytlie HA; Hvid M; Lindgreen E; Kofod-Olsen E; Petersen EL; Jørgensen A; Deleuran M; Vestergaard C; Deleuran B
Cytokine; 2010 Jan; 49(1):24-9. PubMed ID: 19942450
[TBL] [Abstract][Full Text] [Related]
8. [Changes of TRGV genes and prognosis-related chemokine/receptor gene expressions in T cell lymphoma].
Luo Q; Jin Z; Chen S; Yang L; Li B; Li W; Li Y; Wu X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Mar; 33(3):362-366. PubMed ID: 28274317
[TBL] [Abstract][Full Text] [Related]
9. CCL22-specific Antibodies Reveal That Engagement of Two Distinct Binding Domains on CCL22 Is Required for CCR4-mediated Function.
Santulli-Marotto S; Wheeler J; Lacy ER; Boakye K; Luongo J; Wu SJ; Ryan M
Monoclon Antib Immunodiagn Immunother; 2015 Dec; 34(6):373-80. PubMed ID: 26683175
[TBL] [Abstract][Full Text] [Related]
10. Genetic Polymorphisms of CCL22 and CCR4 in Patients with Lung Cancer.
Erfani N; Nedaei Ahmadi AS; Ghayumi MA; Mojtahedi Z
Iran J Med Sci; 2014 Jul; 39(4):367-73. PubMed ID: 25031489
[TBL] [Abstract][Full Text] [Related]
11. Tax-inducible production of CC chemokine ligand 22 by human T cell leukemia virus type 1 (HTLV-1)-infected T cells promotes preferential transmission of HTLV-1 to CCR4-expressing CD4+ T cells.
Hieshima K; Nagakubo D; Nakayama T; Shirakawa AK; Jin Z; Yoshie O
J Immunol; 2008 Jan; 180(2):931-9. PubMed ID: 18178833
[TBL] [Abstract][Full Text] [Related]
12. Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor.
Bonecchi R; Locati M; Galliera E; Vulcano M; Sironi M; Fra AM; Gobbi M; Vecchi A; Sozzani S; Haribabu B; Van Damme J; Mantovani A
J Immunol; 2004 Apr; 172(8):4972-6. PubMed ID: 15067078
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphism in chemokine CCL22 and susceptibility to Helicobacter pylori infection-related gastric carcinoma.
Wang G; Yu D; Tan W; Zhao D; Wu C; Lin D
Cancer; 2009 Jun; 115(11):2430-7. PubMed ID: 19298002
[TBL] [Abstract][Full Text] [Related]
14. Radiation-Enhanced Expression of CCL22 in Nasopharyngeal Carcinoma is Associated With CCR4
Li H; Chen X; Zeng W; Zhou W; Zhou Q; Wang Z; Jiang W; Xie B; Sun LQ
Int J Radiat Oncol Biol Phys; 2020 Sep; 108(1):126-139. PubMed ID: 32428547
[TBL] [Abstract][Full Text] [Related]
15. Interaction between MMP-9 gene polymorphisms and smoking in relation to myocardial infarction in a Uighur population.
Wang L; Ma YT; Xie X; Yang YN; Fu ZY; Li XM; Liu F; Huang Y; Ma X; Chen BD; Yuan S; Sun MH; Peng X; Wang BZ
Clin Appl Thromb Hemost; 2012; 18(1):72-8. PubMed ID: 21733941
[TBL] [Abstract][Full Text] [Related]
16. Novel genetic associations and gene-gene interactions of chemokine receptor and chemokine genetic polymorphisms in HIV/AIDS.
Valverde-Villegas JM; de Medeiros RM; de Andrade KP; Jacovas VC; Dos Santos BR; Simon D; de Matos Almeida SE; Chies JAB
AIDS; 2017 Jun; 31(9):1235-1243. PubMed ID: 28358741
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of the NOS3 gene and risk of myocardial infarction in the Tunisian population.
Kallel A; Sbaï MH; Sediri Y; Abdessalem S; Mourali MS; Feki M; Mechmeche R; Jemaa R; Kaabachi N
Cytokine; 2013 Dec; 64(3):646-51. PubMed ID: 24095258
[TBL] [Abstract][Full Text] [Related]
18. Influences of IL-1b-3953 C>T and MMP-9-1562C >T Gene Variants on Myocardial Infarction Susceptibility in a Subset of the Iranian Population.
Daraei A; Mansoori Y; Zendebad Z; Tavakkoly-Bazzaz J; Madadizadeh F; Naghizadeh MM; Arghavani A; Mansoori B
Genet Test Mol Biomarkers; 2017 Jan; 21(1):33-38. PubMed ID: 27824519
[TBL] [Abstract][Full Text] [Related]
19. CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma.
Kumai T; Nagato T; Kobayashi H; Komabayashi Y; Ueda S; Kishibe K; Ohkuri T; Takahara M; Celis E; Harabuchi Y
Cancer Immunol Immunother; 2015 Jun; 64(6):697-705. PubMed ID: 25754123
[TBL] [Abstract][Full Text] [Related]
20. The SDF1 A/G Gene Variant: A Susceptibility Variant for Myocardial Infarction.
Mansoori Y; Daraei A; Zendebad Z; Madadizadeh F; Mansoori B; Naghizadeh MM; Darbeheshti F
Genet Test Mol Biomarkers; 2017 Aug; 21(8):506-511. PubMed ID: 28650670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
